MCKENZIE TURNER: Open Payments
NPI 1962280750 · PITTSBURG, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 31 payments from 11 companies in 2025. Trend: 2023 $131 · 2024 $111 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $220 |
| Astellas Pharma US Inc | 3 | $76 |
| Lilly USA, LLC | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: UBRELVY, Veozah, VRAYLAR, REXULTI, QULIPTA, MOUNJARO, PREVNAR 20, GEMTESA.
Industry payments across KS — which companies pay providers there.
